Cooper Companies (COO) Liabilities from Discontinued Operations (2021 - 2022)
Cooper Companies (COO) posted Liabilities from Discontinued Operations of $19.0 million for Q1 2022, up 1017.65% on a QoQ basis from $1.7 million in Q4 2021.
Powered by 
Analysis
Cooper Companies (COO) Liabilities from Discontinued Operations (2021 - 2022) Analysis & Trends
Cooper Companies has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at $19.0 million in Q1 2022.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $19.0 million in Q1 2022; TTM through Jan 2022 was $19.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $1.7 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations was $19.0 million for Q1 2022 at Cooper Companies, up from $1.7 million in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was $19.0 million in Q1 2022, with the low at $1.6 million in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2022 | 19.00 Mn |
| Oct 31, 2021 | 1.70 Mn |
| Jul 31, 2021 | 1.60 Mn |